Low physical activity and obesity: causes of chronic disease or simply predictors?

BACKGROUND AND PURPOSE Many studies have shown associations between risk of morbidity and mortality with both obesity and low physical activity (PA), but association does not imply causality. Moreover, there is an inverse relationship between PA and obesity; therefore, controlling for one of these factors when investigating the risk associated with the other is essential. The purpose of this review is to determine whether low PA and obesity actually cause metabolic dysfunction and chronic disease, especially type 2 diabetes (T2D), rather than simply operating as predictors or markers. METHODS The case for causality is strengthened if the following two conditions are satisfied: first, that significant associations between obesity or low PA and risk persist after controlling appropriately; and second, that the physiological mechanisms by which obesity or low PA may exert a causal effect are clearly established. The studies examined include those that have used cardiorespiratory (CR) fitness as a surrogate measure for PA, thus also providing evidence for low CR fitness as an independent risk factor in its own right. RESULTS AND CONCLUSIONS Low PA and poor CR fitness are independent predictors of mortality related to type 2 diabetes and chronic disease in general. Together with well-demonstrated mechanisms, there is strong evidence that low PA and low CR fitness are direct, independent causes of metabolic dysfunction and type 2 diabetes. Despite some reports to the contrary, there is evidence that both general and visceral obesity are predictors of mortality and morbidity after controlling for PA. However, in the absence of established mechanisms, evidence is insufficient to conclude that either general or visceral obesity is a direct, independent cause of metabolic dysfunction or type 2 diabetes.

[1]  V. Montori,et al.  Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies , 2006, The Lancet.

[2]  J. Wylie-Rosett,et al.  Exercise, body mass index, caloric intake, and cardiovascular mortality. , 2003, American journal of preventive medicine.

[3]  A. Tjønneland,et al.  Waist circumference and body composition in relation to all-cause mortality in middle-aged men and women , 2005, International Journal of Obesity.

[4]  R. Unger,et al.  Liporegulation in Diet-induced Obesity , 2001, The Journal of Biological Chemistry.

[5]  H. Lodish,et al.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Kriska,et al.  Association of physical activity and serum insulin concentrations in two populations at high risk for type 2 diabetes but differing by BMI. , 2001, Diabetes care.

[7]  M. Febbraio,et al.  Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects , 2003, Pflügers Archiv.

[8]  E. Shafrir,et al.  Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage , 2005, Diabetes/metabolism research and reviews.

[9]  J. Stevens,et al.  Fitness and fatness as predictors of mortality from all causes and from cardiovascular disease in men and women in the lipid research clinics study. , 2002, American journal of epidemiology.

[10]  K. Reynolds,et al.  Body weight and mortality among men and women in China. , 2006, JAMA.

[11]  R. Ross,et al.  Visceral Fat Is an Independent Predictor of All‐cause Mortality in Men , 2006, Obesity.

[12]  J. Tuomilehto,et al.  Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women. , 2004, European heart journal.

[13]  G. Fantuzzi Adipose tissue, adipokines, and inflammation. , 2005, The Journal of allergy and clinical immunology.

[14]  Jacqueline Capeau,et al.  Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.

[15]  S. Blair,et al.  Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. , 1999, The American journal of clinical nutrition.

[16]  J. Hawley Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance , 2004, Diabetes/metabolism research and reviews.

[17]  J. P. Warne,et al.  Tumour necrosis factor alpha: a key regulator of adipose tissue mass. , 2003, The Journal of endocrinology.

[18]  M. Maffei,et al.  Roles of skeletal muscle and peroxisome proliferator-activated receptors in the development and treatment of obesity. , 2006, Endocrine reviews.

[19]  P. Arner,et al.  Downregulation of Electron Transport Chain Genes in Visceral Adipose Tissue in Type 2 Diabetes Independent of Obesity and Possibly Involving Tumor Necrosis Factor-α , 2006, Diabetes.

[20]  L. Summers Adipose tissue metabolism, diabetes and vascular disease — lessons from in vivo studies , 2006, Diabetes & vascular disease research.

[21]  S. Gordon,et al.  Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. , 2002, Journal of applied physiology.

[22]  Peter Arner,et al.  Use of waist circumference to predict insulin resistance: retrospective study , 2005, BMJ : British Medical Journal.

[23]  B. Saltin,et al.  Evidence for prescribing exercise as therapy in chronic disease , 2006, Scandinavian journal of medicine & science in sports.

[24]  T. Funahashi,et al.  Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese mice. , 2003, Diabetes.

[25]  Tamara B Harris,et al.  Daily activity energy expenditure and mortality among older adults. , 2006, JAMA.

[26]  石田 裕子,et al.  皮膚創傷治癒とIL-1 receptor antagonist (IL-1ra) , 2007 .

[27]  C. Bogardus,et al.  Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21--q23 and is associated with a common polymorphism in LMNA in Pima Indians. , 2001, Molecular genetics and metabolism.

[28]  R S Paffenbarger,et al.  Measurement of physical activity to assess health effects in free-living populations. , 1993, Medicine and science in sports and exercise.

[29]  S. Blair,et al.  Physical fitness and activity as separate heart disease risk factors: a meta-analysis. , 2001, Medicine and science in sports and exercise.

[30]  S. Blair,et al.  Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. , 2005, Archives of internal medicine.

[31]  J. Manson,et al.  Relationship of physical activity vs body mass index with type 2 diabetes in women. , 2004, JAMA.

[32]  R. Ross,et al.  Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. , 2004, Obesity research.

[33]  S. Blair,et al.  The relation of body mass index, cardiorespiratory fitness, and all-cause mortality in women. , 2002, Obesity research.

[34]  T. Kizaki,et al.  Exercise training increases membrane bound form of tumor necrosis factor-alpha receptors with decreases in the secretion of soluble forms of receptors in rat adipocytes. , 2002, Life sciences.

[35]  B. Kahn,et al.  Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. , 1999, The New England journal of medicine.

[36]  S. Blair,et al.  The fitness, obesity, and health equation: is physical activity the common denominator? , 2004, JAMA.

[37]  J. Kaprio,et al.  Natural selection to sports, later physical activity habits, and coronary heart disease , 2000, British journal of sports medicine.

[38]  U. Ekelund,et al.  Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. , 2005, Obesity research.

[39]  M. Jensen Is Visceral Fat Involved in the Pathogenesis of the Metabolic Syndrome? Human Model , 2006, Obesity.

[40]  Walter C Willett,et al.  Exercise type and intensity in relation to coronary heart disease in men. , 2002, JAMA.

[41]  C. Mantzoros,et al.  Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. , 2006, The Journal of clinical endocrinology and metabolism.

[42]  Philip A Kern,et al.  Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. , 2003, Diabetes.

[43]  R. DeFronzo,et al.  Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. , 1985, The Journal of clinical investigation.

[44]  D. Seals,et al.  Fatness Is a Better Predictor of Cardiovascular Disease Risk Factor Profile Than Aerobic Fitness in Healthy Men , 2005, Circulation.

[45]  J. Manson,et al.  Walking compared with vigorous exercise for the prevention of cardiovascular events in women. , 2002, The New England journal of medicine.

[46]  K. Alberti,et al.  Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes. , 2000, Archives of internal medicine.

[47]  T. Funahashi,et al.  Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. , 2003, Diabetes.

[48]  Commentary: current perspectives on obesity and health: black and white, or shades of grey? , 2006, International journal of epidemiology.

[49]  D. Kelley,et al.  Metabolic flexibility , 2004, The Proceedings of the Nutrition Society.

[50]  E. Ravussin,et al.  Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. , 2006, Diabetes care.

[51]  B. Kingwell Nitric oxide‐mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  J. Bülow,et al.  Effect of training on insulin sensitivity of glucose uptake and lipolysis in human adipose tissue. , 2000, American journal of physiology. Endocrinology and metabolism.

[53]  G. Kojda,et al.  Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. , 2000, The Journal of clinical investigation.

[54]  Ian Janssen,et al.  Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. , 2005, Diabetes care.

[55]  J. Simoneau,et al.  Skeletal muscle utilization of free fatty acids in women with visceral obesity. , 1995, The Journal of clinical investigation.

[56]  Pierre Dupont,et al.  Regional Differences in Adipose Tissue Metabolism in Women , 2006, Diabetes.

[57]  Andrew R Coggan,et al.  Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. , 2004, The New England journal of medicine.

[58]  J. Karjalainen,et al.  Muscle fiber-type distribution predicts weight gain and unfavorable left ventricular geometry: a 19 year follow-up study , 2006, BMC cardiovascular disorders.

[59]  M. Visser,et al.  What aspects of body fat are particularly hazardous and how do we measure them? , 2006, International journal of epidemiology.

[60]  B. Saltin,et al.  Letter regarding article by Christou et al, "Fatness is a better predictor of cardiovascular disease risk factor profile than aerobic fitness in healthy men". , 2005, Circulation.

[61]  Walter C Willett,et al.  Obesity as Compared With Physical Activity in Predicting Risk of Coronary Heart Disease in Women , 2006, Circulation.

[62]  K. Frayn,et al.  Adipose tissue as a buffer for daily lipid flux , 2002, Diabetologia.

[63]  H. Sesso,et al.  Joint Effects of Physical Activity and Body Weight on Diabetes and Cardiovascular Disease , 2006, Exercise and sport sciences reviews.

[64]  K. Eriksson,et al.  No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise , 1998, Diabetologia.

[65]  P. Ernsberger,et al.  The epidemiology of overweight and obesity: public health crisis or moral panic? , 2006, International journal of epidemiology.

[66]  D. Kelley Skeletal muscle fat oxidation: timing and flexibility are everything. , 2005, The Journal of clinical investigation.

[67]  G. Heigenhauser,et al.  Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. , 2002, American journal of physiology. Endocrinology and metabolism.

[68]  B. Nicklas,et al.  Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training , 2005, Canadian Medical Association Journal.

[69]  S. Blair,et al.  Objectively measured physical activity and mortality in older adults. , 2006, JAMA.

[70]  E. Ravussin,et al.  Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. , 1990, The American journal of physiology.

[71]  G. Bray,et al.  Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor. , 2005, The Journal of clinical investigation.

[72]  Bente Klarlund Pedersen,et al.  The anti-inflammatory effect of exercise. , 2005, Journal of applied physiology.

[73]  B. Harrison,et al.  Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse. , 2001, Journal of applied physiology.